Analysts think big returns could be on offer from this biotech giant. The post CSL shares haven't been this cheap in 9 years: ...

I maintain a Neutral view on CSL Limited due to the mixed prospects for its flu vaccine (Seqirus) and plasma therapy (Behring ...

Let's see if analysts think investors should be buying the dip with this quality stock. The post CSL is approaching a 5-year ...

Atlas Funds’ Phil Cornet says the weakness in the ASX 200 heavyweight makes no sense and Ampol is ripe for a rally.

CSL shares will pay a 9% higher interim dividend of US$1.30 per share on 9 April. Here's when the ASX healthcare giant will go ex-dividend.

Morgan Stanley initiated coverage of CSL (CSLLY) with an Overweight rating and A$313 price target A “solid revenue growth outlook” and margin ...

CSL Limited ( ASX:CSL ) stock is about to trade ex-dividend in 2 days. The ex-dividend date is usually set to be ...

There is a good chance that UK-based football supporters know Chelsea is an area of London, so CFC LDN isn’t targeted at them ...

Learn More CSL Ltd (ASX: CSL) shares had another poor session on Wednesday. The biotechnology company's shares were down 1.5% to $252.92. This means that they are now down 20% from their 52-week high.